RE: Great RNS Just Released on 2 NED Appintments!21 Dec 2023 13:49
It looks as though Nanoco have delivered on every 2023 objective set after the Samsung settlement, including a first commercial order (first of many) and the appointment of not one, but two non-execs with incredible contacts and commercialisation experience.
With validated IP, competitors crumbling, full manufacturing in place, strong partnerships with the likes of STMicro and fully funded for years, I've always thought that commercialisation was the weak point. Lets hope the new NEDs improve how Nanoco commercialise and build customer partnerships.
I'm looking forward to the details of the return to shareholders in Q124 and more commercial orders and partnerships throughout 2024.
Happy Christmas and GLA, I'm very happy to hold and see loads of upside.